Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 11

1.

Artemisinin resistance in Plasmodium falciparum malaria.

Dondorp AM, Nosten F, Yi P, Das D, Phyo AP, Tarning J, Lwin KM, Ariey F, Hanpithakpong W, Lee SJ, Ringwald P, Silamut K, Imwong M, Chotivanich K, Lim P, Herdman T, An SS, Yeung S, Singhasivanon P, Day NP, Lindegardh N, Socheat D, White NJ.

N Engl J Med. 2009 Jul 30;361(5):455-67. doi: 10.1056/NEJMoa0808859. Erratum in: N Engl J Med. 2009 Oct 22;361(17):1714.

2.

Strong gametocytocidal effect of methylene blue-based combination therapy against falciparum malaria: a randomised controlled trial.

Coulibaly B, Zoungrana A, Mockenhaupt FP, Schirmer RH, Klose C, Mansmann U, Meissner PE, Müller O.

PLoS One. 2009;4(5):e5318. doi: 10.1371/journal.pone.0005318. Epub 2009 May 5.

3.

Methylene blue for malaria in Africa: results from a dose-finding study in combination with chloroquine.

Meissner PE, Mandi G, Coulibaly B, Witte S, Tapsoba T, Mansmann U, Rengelshausen J, Schiek W, Jahn A, Walter-Sack I, Mikus G, Burhenne J, Riedel KD, Schirmer RH, Kouyaté B, Müller O.

Malar J. 2006 Oct 8;5:84.

4.

Eosin B as a novel antimalarial agent for drug-resistant Plasmodium falciparum.

Massimine KM, McIntosh MT, Doan LT, Atreya CE, Gromer S, Sirawaraporn W, Elliott DA, Joiner KA, Schirmer RH, Anderson KS.

Antimicrob Agents Chemother. 2006 Sep;50(9):3132-41.

5.
6.

Safety of the methylene blue plus chloroquine combination in the treatment of uncomplicated falciparum malaria in young children of Burkina Faso [ISRCTN27290841].

Meissner PE, Mandi G, Witte S, Coulibaly B, Mansmann U, Rengelshausen J, Schiek W, Jahn A, Sanon M, Tapsoba T, Walter-Sack I, Mikus G, Burhenne J, Riedel KD, Schirmer H, Kouyaté B, Müller O.

Malar J. 2005 Sep 22;4:45.

7.

Safety of the combination of chloroquine and methylene blue in healthy adult men with G6PD deficiency from rural Burkina Faso.

Mandi G, Witte S, Meissner P, Coulibaly B, Mansmann U, Rengelshausen J, Schiek W, Jahn A, Sanon M, Wüst K, Walter-Sack I, Mikus G, Burhenne J, Riedel KD, Schirmer H, Kouyaté B, Müller O.

Trop Med Int Health. 2005 Jan;10(1):32-8.

8.
9.

A molecular docking strategy identifies Eosin B as a non-active site inhibitor of protozoal bifunctional thymidylate synthase-dihydrofolate reductase.

Atreya CE, Johnson EF, Irwin JJ, Dow A, Massimine KM, Coppens I, Stempliuk V, Beverley S, Joiner KA, Shoichet BK, Anderson KS.

J Biol Chem. 2003 Apr 18;278(16):14092-100. Epub 2003 Jan 29.

10.

Antimalarial dyes revisited: xanthenes, azines, oxazines, and thiazines.

Vennerstrom JL, Makler MT, Angerhofer CK, Williams JA.

Antimicrob Agents Chemother. 1995 Dec;39(12):2671-7.

11.

Drug resistance in Plasmodium berghei Vincke and Lips, 1948. I. Chloroquine resistance.

Peters W.

Exp Parasitol. 1965 Aug;17(1):80-9. No abstract available.

PMID:
5843289

Supplemental Content

Support Center